TRPA1 Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the TRPA1 gene, its protein product, associated diseases, expression patterns, and mutations.

Gene Information Card

Symbol TRPA1
Full Name Transient receptor potential cation channel subfamily A member 1
Gene Type protein coding
Chromosomal Location 8q21.11
NCBI Gene ID 8989 ncbi.nlm.nih.gov/gene/8989
Ensembl ID ENSG00000104325
UniProt ID O75762
OMIM ID 604775
HGNC ID 17116
Aliases ANKTM1, FEPS1, TRPA1

Description

The TRPA1 gene encodes a member of the transient receptor potential (TRP) family of ion channels. TRPA1 is a calcium-permeable, non-selective cation channel that is activated by various chemical irritants, cold temperatures, and inflammatory mediators. It is primarily expressed in sensory neurons and plays a critical role in pain sensation, neurogenic inflammation, and nociception. TRPA1 is involved in the detection of environmental irritants such as mustard oil, cinnamaldehyde, and acrolein, and is implicated in pain hypersensitivity and chronic pain conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Episodic pain syndrome, familial, 1 (FEPS1) Gain-of-function mutations in TRPA1 lead to hyperexcitability of sensory neurons, causing spontaneous pain episodes. OMIM: 604775; ClinVar: Pathogenic variants (e.g., p.Asn855Ser) associated with FEPS1.
Chronic pain disorders (e.g., neuropathic pain, inflammatory pain) TRPA1 activation by inflammatory mediators and oxidative stress contributes to pain sensitization and chronic pain. PubMed: Numerous studies; ClinVar: Variants of uncertain significance in pain cohorts.
Asthma and airway inflammation TRPA1 activation by environmental irritants induces neurogenic inflammation in airways, contributing to asthma pathophysiology. PubMed: Animal models and human studies; OMIM: Not directly listed, but TRPA1 is a therapeutic target.
Migraine TRPA1 activation by endogenous or exogenous triggers may mediate meningeal nociception and migraine pain. PubMed: Preclinical studies; ClinVar: No direct germline variants, but expression in trigeminal ganglia.

Expression Profile

Tissue Expression
Tissue nTPM level
Sensory ganglia (dorsal root ganglia, trigeminal ganglia) Not available (nTPM not applicable for neuronal tissues) High expression in nociceptive neurons
Lung Low Low expression in airway epithelial cells and sensory nerve fibers
Colon Low Low expression in enteric neurons and epithelial cells
Skin Low Expression in sensory nerve endings in epidermis and dermis
Bladder Low Expression in sensory nerves innervating bladder
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) Not available Endogenous expression; used in neuronal differentiation studies
HEK293 (embryonic kidney) Not available Commonly used for heterologous expression of TRPA1 in functional assays
A549 (lung carcinoma) Not available Low endogenous expression; used in airway inflammation studies
HaCaT (keratinocyte) Not available Expression in keratinocytes; involved in skin barrier and inflammation
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Asn855Ser (c.2564A>G) Missense Rare (found in FEPS1 families) Gain-of-function: increases channel activity and neuronal excitability
p.Glu179Lys (c.535G>A) Missense Rare (reported in FEPS1) Gain-of-function: alters channel gating
p.Arg58Cys (c.172C>T) Missense Rare (reported in FEPS1) Gain-of-function: enhances activation by agonists
p.Val975Met (c.2923G>A) Missense Rare (reported in FEPS1) Gain-of-function: increases basal activity
p.Leu528Pro (c.1583T>C) Missense Rare (reported in FEPS1) Gain-of-function: alters channel kinetics
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in TRPA1 are rare and not well characterized. Some variants may reduce channel expression or activity, potentially leading to impaired pain sensation, but no specific disease has been firmly associated with loss-of-function in humans.

Gain of Function (GOF)

Gain-of-function mutations are the primary pathogenic mechanism in familial episodic pain syndrome 1 (FEPS1). These mutations increase channel opening probability, enhance calcium influx, and cause hyperexcitability of sensory neurons, leading to spontaneous pain episodes.

Dominant Negative (DN)

No dominant-negative mutations have been reported for TRPA1. The channel functions as a tetramer, and most pathogenic variants are gain-of-function with dominant inheritance.

Pathways

Pain sensation and nociception
Neurogenic inflammation
Thermosensation (cold and heat)
Chemical irritant detection
Inflammatory mediator signaling (e.g.
bradykinin
prostaglandins)
Oxidative stress response
TRP channel signaling

Protein Summary

The TRPA1 protein is a 1,119-amino acid, six-transmembrane domain ion channel that forms tetramers. It contains multiple ankyrin repeats in its N-terminal cytoplasmic domain, which are involved in protein-protein interactions and channel regulation. TRPA1 is activated by electrophilic compounds that covalently modify cysteine residues, as well as by non-electrophilic activators like cold and mechanical stimuli. Upon activation, it mediates calcium and sodium influx, leading to membrane depolarization and neuronal excitation. TRPA1 is a key player in the detection of noxious stimuli and is a major target for analgesic drug development.

Related Products

Product name Cat.No. Species Gene ID
TRPA1 Overexpression HEK293 Stable Cell Line EDJ-GQ74 Human 8989 Details Get a Quote
TRPA1 Knockout HEK293 Cell Line EDJ-KQ1284 Human 8989 Details Get a Quote
TRPA1 Knockout A-549 Cell Line EDJ-KQ21981 Human 8989 Details Get a Quote
TRPA1 Knockout HeLa Cell Line EDJ-KQ21983 Human 8989 Details Get a Quote
TRPA1 Knockout HCT 116 Cell Line EDJ-KQ72001 Human 8989 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: